Literature DB >> 28457925

Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.

Ivan J Lee1, Robert J Lee2, Daniel K Fahim3.   

Abstract

OBJECTIVE: To evaluate prognostic factors of patients with chordoma through a population-based analysis.
METHODS: Surveillance, Epidemiology, and End Results (SEER) database was queried for patients with chordoma from 1973 to 2013. Kaplan-Meier univariate analysis and Cox regression multivariate analysis were performed to examine prognostic factors in overall survival (OS) and disease-specific survival (DSS).
RESULTS: One thousand five hundred ninety-eight patients with chordoma are identified. Kaplan-Meier analysis showed that OS and DSS were 61% and 71% at 5 years and 41% and 57% at 10 years. Multivariate Cox regression analysis demonstrated that independent predictors of OS and DSS are age at diagnosis (hazard ratio [HR]= 2.80 [95% confidence interval {CI}, 2.12-3.70], P < 0.001; HR = 1.60 [95% CI, 1.18-2.16], P = 0.002), surgical treatment (HR = 0.62 [95% CI, 0.52-0.73], P < 0.001; HR = 0.64 [95% CI, 0.52-0.79], P < 0.001), radiation therapy (HR = 1.23 [95% CI, 1.07-1.42], P = 0.004; HR = 1.29 [95% CI, 1.09-1.54], P = 0.004), tumor size (HR = 1.53 [95% CI, 1.32-1.78], P < 0.001; HR = 1.62 [95% CI, 1.35-1.94], P < 0.001) and distant metastasis (HR = 3.40 [95% CI, 2.45-4.71], P < 0.001; HR = 3.77 [95% CI, 2.61-5.45], P < 0.001).
CONCLUSION: We report the largest study to date to evaluate prognostic factors of patients with chordoma. Multivariate analysis demonstrated that older age, greater tumor size, and distant metastasis were correlated with decreased survival, whereas surgical resection was correlated with increased survival. Patients receiving radiation therapy also showed decreased survival, likely an indication of the patients' advanced stage of disease, making them poor surgical candidates.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chordoma; SEER Program; Survival analysis

Mesh:

Year:  2017        PMID: 28457925     DOI: 10.1016/j.wneu.2017.04.118

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  17 in total

1.  Peri-operative prognostic factors for primary skull base chordomas: results from a single-center cohort.

Authors:  Emanuele La Corte; Morgan Broggi; Alberto Raggi; Silvia Schiavolin; Francesco Acerbi; Giovanni Danesi; Mariangela Farinotti; Giovanni Felisati; Alberto Maccari; Bianca Pollo; Marco Saini; Claudia Toppo; Francesca Valvo; Riccardo Ghidoni; Maria Grazia Bruzzone; Francesco DiMeco; Paolo Ferroli
Journal:  Acta Neurochir (Wien)       Date:  2020-01-16       Impact factor: 2.216

2.  The top 50 cited articles on chordomas.

Authors:  Tochukwu Ikpeze; Addisu Mesfin
Journal:  J Spine Surg       Date:  2018-03

3.  Chordoma of the mobile spine and sacrum: clinical management and prognosis.

Authors:  Taylor D'Amore; Brendan Boyce; Addisu Mesfin
Journal:  J Spine Surg       Date:  2018-09

4.  Genetic landscape and ligand-dependent activation of sonic hedgehog-Gli1 signaling in chordomas: a novel therapeutic target.

Authors:  Chenlong Yang; Lei Yong; Chen Liang; Yan Li; Yunlong Ma; Feng Wei; Liang Jiang; Hua Zhou; Guanping He; Xiaoyu Pan; Bao Hai; Jian Wu; Yulun Xu; Zhongjun Liu; Xiaoguang Liu
Journal:  Oncogene       Date:  2020-05-14       Impact factor: 9.867

5.  Targeted Therapy for Chordoma: Key Molecular Signaling Pathways and the Role of Multimodal Therapy.

Authors:  Oluwaseun O Akinduro; Paola Suarez-Meade; Diogo Garcia; Desmond A Brown; Rachel Sarabia-Estrada; Steven Attia; Ziya L Gokaslan; Alfredo Quiñones-Hinojosa
Journal:  Target Oncol       Date:  2021-04-24       Impact factor: 4.864

6.  The Role of Radiotherapy for Chordoma Patients Managed With Surgery: Analysis of the National Cancer Database.

Authors:  Brian L Dial; David L Kerr; Alexander L Lazarides; Anthony A Catanzano; Cindy L Green; Thomas Risoli; Dan G Blazer; Rory C Goodwin; Brian E Brigman; William C Eward; Nicole A Larrier; David G Kirsch; Sergio A Mendoza-Lattes
Journal:  Spine (Phila Pa 1976)       Date:  2020-06-15       Impact factor: 3.241

7.  Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.

Authors:  Yue Pan; Lingyun Lu; Junquan Chen; Yong Zhong; Zhehao Dai
Journal:  J Orthop Surg Res       Date:  2018-04-06       Impact factor: 2.359

Review 8.  State-of-the-Art Imaging in Human Chordoma of the Skull Base.

Authors:  Rene G C Santegoeds; Yasin Temel; Jan C Beckervordersandforth; Jacobus J Van Overbeeke; Christianne M Hoeberigs
Journal:  Curr Radiol Rep       Date:  2018-04-03

9.  Influence of marital status on overall survival in adult patients with chordoma: a SEER-based study.

Authors:  Chao Tang; Ruiliang Wang; Qingguo Lu; Shantao Wang; Gen Jia; Pengfei Cao; Xinfa Nie; Hailong Zhang
Journal:  J Orthop Surg Res       Date:  2020-07-23       Impact factor: 2.359

10.  Association between patient age and the risk of mortality following local recurrence of a sacral chordoma.

Authors:  Matthew T Houdek; Mario Hevesi; Joseph H Schwab; Michael J Yaszemski; Anthony M Griffin; John H Healey; Peter C Ferguson; Francis J Hornicek; Patrick J Boland; Franklin H Sim; Peter S Rose; Jay S Wunder
Journal:  J Surg Oncol       Date:  2019-11-22       Impact factor: 2.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.